Fairfield, Bush & Co. Pfizer Inc Transaction History

Fairfield, Bush & Co.

$170 Billion
Q4 2024

A detailed history of Fairfield, Bush & Co. transactions in Pfizer Inc stock. As of the latest transaction made, Fairfield, Bush & Co. holds 34,664 shares of PFE stock, worth $916,169. This represents 0.54% of its overall portfolio holdings.

Number of Shares

34,664

Previous 26,383 31.39%

Holding current value

$916,169

Previous $764 Million 20.45%

% of portfolio

0.54%

Previous 0.45%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$24.8 - $30.19 $205,368 - $250,003	8,281 Added 31.39%	34,664 $920 Million
Q3 2024 Nov 12, 2024	BUY	$27.7 - $31.39 $193,290 - $219,039	6,978 Added 35.96%	26,383 $764 Million
Q2 2024 Aug 15, 2024	BUY	$25.26 - $29.6 $57,517 - $67,399	2,277 Added 13.29%	19,405 $543 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $54,135 - $62,165	2,091 Added 13.91%	17,128 $475 Million
Q3 2023 Nov 15, 2023	SELL	$32.09 - $37.51 $683,517 - $798,963	-21,300 Reduced 58.62%	15,037 $499 Million
Q2 2023 Aug 15, 2023	BUY	$36.12 - $41.79 $220,331 - $254,919	6,100 Added 20.17%	36,337 $1.33 Billion
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $571,194 - $743,611	14,501 Added 92.15%	30,237 $1.23 Billion
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $2,755 - $3,597	66 Added 0.42%	15,736 $806 Million
Q3 2022 Nov 07, 2022	BUY	$43.76 - $53.42 $8,752 - $10,684	200 Added 1.29%	15,670 $686,000
Q2 2022 Aug 09, 2022	SELL	$46.53 - $55.17 $25,591 - $30,343	-550 Reduced 3.43%	15,470 $811,000
Q1 2022 May 06, 2022	SELL	$45.75 - $56.69 $13,679 - $16,950	-299 Reduced 1.83%	16,020 $829,000
Q4 2021 May 12, 2022	SELL	$41.32 - $61.25 $3,099 - $4,593	-75 Reduced 0.46%	16,319 $964,000
Q4 2021 Feb 09, 2022	SELL	$41.32 - $61.25 $668,351 - $990,718	-16,175 Reduced 49.66%	16,394 $968,000
Q3 2021 Nov 08, 2021	BUY	$39.25 - $50.42 $134,274 - $172,486	3,421 Added 11.74%	32,569 $1.4 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $16,745 - $18,885	-500 Reduced 1.69%	29,148 $1.06 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $9,472 - $12,044	-283 Reduced 0.95%	29,648 $1.09 Million
Q1 2020 May 13, 2020	BUY	$27.03 - $38.62 $2,703 - $3,861	100 Added 0.34%	29,931 $977,000
Q4 2019 Feb 12, 2020	SELL	$32.92 - $37.36 $24,130 - $27,384	-733 Reduced 2.4%	29,831 $1.11 Million
Q3 2019 Nov 13, 2019	BUY	$32.49 - $42.13 $1,039 - $1,348	32 Added 0.1%	30,564 $1.1 Million
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $14,126 - $15,860	-382 Reduced 1.24%	30,532 $1.32 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $237,637 - $261,084	-6,337 Reduced 17.01%	30,914 $1.31 Million
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $5,770 - $6,579	-150 Reduced 0.4%	37,251 $1.63 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $189,585 - $229,955	5,500 Added 17.24%	37,401 $1.65 Million
Q2 2018 Aug 16, 2018	SELL	$32.98 - $35.16 $273,503 - $291,581	-8,293 Reduced 20.63%	31,901 $1.16 Million
Q1 2018 May 09, 2018	SELL	$31.91 - $37.02 $191,460 - $222,120	-6,000 Reduced 12.99%	40,194 $1.43 Million
Q4 2017 Feb 22, 2018	BUY	$33.26 - $35.29 $192,908 - $204,682	5,800 Added 14.36%	46,194 $1.67 Million
Q2 2017 Aug 15, 2017	BUY	N/A	40,394	40,394 $1.36 Million

Others Institutions Holding PFE

# of Institutions

3,367

Shares Held

3.69B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairfield, Bush & Co., based on Form 13F filings with the SEC.

News

Stay updated on Fairfield, Bush & Co. with notifications on news.

Account

Fairfield, Bush & Co. Pfizer Inc Transaction History